Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma Journal Article

  


Authors: Ku, G.; Ilson, D.
Article Title: Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma
Journal Title: Lancet Oncology
Volume: 18
Issue: 5
ISSN: 1470-2045
Publisher: Elsevier Science, Inc.  
Date Published: 2017-05-01
Start Page: e243
Language: English
DOI: 10.1016/s1470-2045(17)30280-2
PROVIDER: scopus
PUBMED: 28495288
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018757147&doi=10.1016%2fS1470-2045%2817%2930280-2&partnerID=40&md5=293dae6729f91d11b7f10d7113bfd27f
Notes: Letter -- Export Date: 2 June 2017 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Geoffrey Yuyat Ku
    230 Ku
  2. David H Ilson
    433 Ilson
Related MSK Work